FREDUN PHARMACEUTICALS
Back to Balance Sheet
|
FREDUN PHARMACEUTICALS Last 5 Year Total Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹327 Cr | ₹167 Cr | ₹140 Cr | ₹74 Cr | ₹86 Cr |
What is the latest Total Current Liabilities ratio of FREDUN PHARMACEUTICALS ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹327 Cr |
| Mar2024 | ₹167 Cr |
| Mar2023 | ₹140 Cr |
| Mar2022 | ₹74 Cr |
| Mar2021 | ₹86 Cr |
How is Total Current Liabilities of FREDUN PHARMACEUTICALS Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹327 Cr | 96.20 | |
| Mar2024 | ₹167 Cr | 19.46 | |
| Mar2023 | ₹140 Cr | 89.36 | |
| Mar2022 | ₹74 Cr | -14.70 | |
| Mar2021 | ₹86 Cr | - | |
Compare Total Current Liabilities of peers of FREDUN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FREDUN PHARMACEUTICALS | ₹1,000.8 Cr | 5.9% | 7.6% | 158.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹396,370.0 Cr | -3.9% | -8.9% | -3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,193.0 Cr | 3.8% | -4.7% | 11.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,438.0 Cr | 3.2% | -5.6% | 26.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,097.0 Cr | 3.3% | -6% | 11% | Stock Analytics | |
| CIPLA | ₹97,846.7 Cr | 0.8% | -9.1% | -13.1% | Stock Analytics | |
FREDUN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FREDUN PHARMACEUTICALS | 5.9% |
7.6% |
158.2% |
| SENSEX | 3.7% |
-0.9% |
0.7% |
You may also like the below Video Courses